Published in PLoS One on February 08, 2011
Histone/protein deacetylases and T-cell immune responses. Blood (2012) 1.14
Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway : scriptaid protects against TBI via AKT. Neurotherapeutics (2013) 1.04
Histone deacetylase 3 is required for maintenance of bone mass during aging. Bone (2012) 1.01
The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity. J Biol Chem (2013) 0.97
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. Nat Commun (2015) 0.93
Imbalance between HAT and HDAC activities in the PBMCs of patients with ankylosing spondylitis or rheumatoid arthritis and influence of HDAC inhibitors on TNF alpha production. PLoS One (2013) 0.89
Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response. Nat Commun (2015) 0.83
HDAC3 acts as a negative regulator of angiogenesis. BMB Rep (2014) 0.81
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis. Ann Clin Transl Neurol (2014) 0.80
Increasing consistency of disease biomarker prediction across datasets. PLoS One (2014) 0.80
Early chronotype and tissue-specific alterations of circadian clock function in spontaneously hypertensive rats. PLoS One (2012) 0.78
Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. PeerJ (2016) 0.77
Apoptosis - an Ubiquitous T cell Immunomodulator. J Clin Cell Immunol (2011) 0.75
Photoreactive "nanorulers" detect a novel conformation of full length HDAC3-SMRT complex in solution. ACS Chem Biol (2013) 0.75
Delphinidin induces apoptosis via cleaved HDAC3-mediated p53 acetylation and oligomerization in prostate cancer cells. Oncotarget (2016) 0.75
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Surfing the p53 network. Nature (2000) 35.36
Controlling the false discovery rate in behavior genetics research. Behav Brain Res (2001) 21.82
Multiple sclerosis. Lancet (2008) 13.77
Multiple sclerosis. N Engl J Med (2000) 12.69
p53 in health and disease. Nat Rev Mol Cell Biol (2007) 11.33
Modes of p53 regulation. Cell (2009) 9.31
Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene (2007) 7.13
Multiple sclerosis--the plaque and its pathogenesis. N Engl J Med (2006) 6.60
Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol (2004) 6.00
Acetylation is indispensable for p53 activation. Cell (2008) 5.70
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol (2003) 5.46
Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol (2007) 4.87
The complexity of p53 stabilization and activation. Cell Death Differ (2006) 3.61
Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol (2008) 3.56
Anti-inflammatory Agents: Present and Future. Cell (2010) 3.13
The mitochondrial p53 pathway. Biochim Biophys Acta (2008) 2.98
Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci (2009) 2.95
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell (2004) 2.66
An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. Biochem Biophys Res Commun (2008) 2.48
Bioconductor: an open source framework for bioinformatics and computational biology. Methods Enzymol (2006) 2.42
Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat Rev Neurosci (2006) 2.07
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 1.89
Chemical mechanisms of histone lysine and arginine modifications. Biochim Biophys Acta (2008) 1.69
p53 acetylation is crucial for its transcription-independent proapoptotic functions. J Biol Chem (2009) 1.48
An integrated approach for the analysis of biological pathways using mixed models. PLoS Genet (2008) 1.40
Biomarkers for predicting clinical responses to HDAC inhibitors. Cancer Lett (2009) 1.31
HDAC3 overexpression and colon cancer cell proliferation and differentiation. Mol Carcinog (2008) 1.29
Isoform-selective histone deacetylase inhibitors. Curr Pharm Des (2008) 1.29
Histone deacetylases: salesmen and customers in the post-translational modification market. Biol Cell (2009) 1.29
Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts. J Rheumatol (2009) 1.21
Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. Br J Haematol (2010) 1.20
Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53. J Biol Chem (2009) 1.17
Novel structural insights into class I and II histone deacetylases. Curr Top Med Chem (2009) 1.17
p53 moves to mitochondria: a turn on the path to apoptosis. Cell Cycle (2004) 1.17
HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells. Cancer Biother Radiopharm (2009) 1.06
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood (2010) 1.05
A unified mixed effects model for gene set analysis of time course microarray experiments. Stat Appl Genet Mol Biol (2009) 1.05
Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol (2010) 1.02
The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression. Proc Natl Acad Sci U S A (2010) 0.99
Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. J Neuroimmunol (2009) 0.97
Regulation of mitochondrial apoptotic events by p53-mediated disruption of complexes between antiapoptotic Bcl-2 members and Bim. J Biol Chem (2010) 0.97
Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed. Cancer Biol Ther (2009) 0.97
Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. J Cell Mol Med (2008) 0.95
Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy. Int J Cancer (2011) 0.95
Defective ATM-p53-mediated apoptotic pathway in multiple sclerosis. Ann Neurol (2005) 0.90
Monitoring of multiple sclerosis immunotherapy: from single candidates to biomarker networks. J Neurol (2008) 0.88
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. Proteomics (2009) 0.87
Identification and characterization of the interferon-beta-mediated p53 signal pathway in human peripheral blood mononuclear cells. Immunology (2009) 0.84
Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. Int J Oncol (2008) 0.83
Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung. Tumour Biol (2010) 0.83
Aberrant transcriptional regulatory network in T cells of multiple sclerosis. Neurosci Lett (2007) 0.78
Current and future applications of transcriptomics for discovery in CNS disease and injury. Neurosignals (2009) 0.78
Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Int J Mol Med (2008) 0.78
A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification. BMC Bioinformatics (2008) 3.81
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One (2008) 3.45
The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health (2001) 3.13
Estimating baseline kidney function in hospitalized patients with impaired kidney function. Clin J Am Soc Nephrol (2012) 2.94
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
Gray matter involvement in multiple sclerosis. Neurology (2007) 2.75
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol (2013) 2.06
Objective measurement of minimal fat in normal skeletal muscles of healthy children using T2 relaxation time mapping (T2 maps) and MR spectroscopy. Pediatr Radiol (2013) 2.03
Aphasic or amnesic status epilepticus detected on PET but not EEG. Epilepsia (2008) 1.81
Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res (2010) 1.79
Characterizing sleep in children with autism spectrum disorders: a multidimensional approach. Sleep (2006) 1.72
Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation. Sleep Med (2007) 1.67
Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record. Pharmacogenomics (2012) 1.66
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol (2011) 1.57
Supervised principal component analysis for gene set enrichment of microarray data with continuous or survival outcomes. Bioinformatics (2008) 1.45
Distinct transcriptomes define rostral and caudal serotonin neurons. J Neurosci (2010) 1.43
Supervising anesthesiologists cannot be effectively compared according to their patients' postanesthesia care unit admission pain scores. Anesth Analg (2015) 1.42
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res (2008) 1.26
Survey of radiology residents: breast imaging training and attitudes. Radiology (2003) 1.26
Development of chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.26
Pathway-based analysis for genome-wide association studies using supervised principal components. Genet Epidemiol (2010) 1.25
Defining the sleep phenotype in children with autism. Dev Neuropsychol (2009) 1.25
Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord (2012) 1.24
Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLoS Comput Biol (2012) 1.23
A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. J Med Genet (2011) 1.15
Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients. J Am Soc Nephrol (2013) 1.11
Diagnostic and therapeutic aspects of Hashimoto's encephalopathy. J Neurol Sci (2013) 1.11
Early hepatic insulin resistance in mice: a metabolomics analysis. Mol Endocrinol (2010) 1.11
Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation. J Neurol (2012) 1.10
Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J Neuroinflammation (2005) 1.10
Evidence of cell-nonautonomous changes in dendrite and dendritic spine morphology in the met-signaling-deficient mouse forebrain. J Comp Neurol (2010) 1.09
Integrating biological knowledge with gene expression profiles for survival prediction of cancer. J Comput Biol (2009) 1.08
Parent-based sleep education workshops in autism. J Child Neurol (2009) 1.08
Pathway-based analysis of GWAS datasets: effective but caution required. Int J Neuropsychopharmacol (2010) 1.08
Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve (2009) 1.05
Infectious causes of multiple sclerosis. Lancet Neurol (2006) 1.04
Relationship between home fruit and vegetable availability and infant and maternal dietary intake in African-American families: evidence from the exhaustive home food inventory. J Am Diet Assoc (2011) 1.00
Biobehavioral profiles of arousal and social motivation in autism spectrum disorders. J Child Psychol Psychiatry (2013) 0.97
Distal sudomotor findings in postural tachycardia syndrome. Clin Auton Res (2009) 0.97
RNA-Seq analysis implicates dysregulation of the immune system in schizophrenia. BMC Genomics (2012) 0.97
Flexible regions within I{kappa}B{alpha} create the ubiquitin-independent degradation signal. J Biol Chem (2010) 0.97
Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationale. J Parkinsons Dis (2012) 0.97
A sleep habits questionnaire for children with autism spectrum disorders. J Child Neurol (2009) 0.96
Genome-wide analysis of copy number variation in type 1 diabetes. PLoS One (2010) 0.96
Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One (2013) 0.96
A pilot study of shoulder placement for actigraphy in children. Behav Sleep Med (2012) 0.95
Comparison of expert and novice performance of a simulated transesophageal echocardiography examination. Simul Healthc (2013) 0.95
Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system. J Immunol (2002) 0.94
An Integrative Pathway-based Clinical-genomic Model for Cancer Survival Prediction. Stat Probab Lett (2010) 0.94
High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Mol Pharmacol (2010) 0.93
Identification of molecular biomarkers for multiple sclerosis. J Mol Diagn (2007) 0.92
Automated extraction of clinical traits of multiple sclerosis in electronic medical records. J Am Med Inform Assoc (2013) 0.92
Defective ATM-p53-mediated apoptotic pathway in multiple sclerosis. Ann Neurol (2005) 0.90
The spectrum of Susac's syndrome. Neurol Sci (2009) 0.90
Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis. J Exp Med (2002) 0.90
Relation of melatonin to sleep architecture in children with autism. J Autism Dev Disord (2011) 0.90
Postictal breathing pattern distinguishes epileptic from nonepileptic convulsive seizures. Epilepsia (2007) 0.90
Prevalence of stroke in Restless Legs Syndrome: Initial Results Point to the Need for More Sophisticated Studies. Open Neurol J (2010) 0.89
Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation. Europace (2013) 0.89
Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep. J Autism Dev Disord (2014) 0.88
Engineering the serine/threonine protein kinase Raf-1 to utilise an orthogonal analogue of ATP substituted at the N6 position. FEBS Lett (2004) 0.88
Improvement in social deficits in autism spectrum disorders using a theatre-based, peer-mediated intervention. Autism Res (2013) 0.88
Outpatient assessment of determinants of glucose excursions in adolescents with type 1 diabetes: proof of concept. Diabetes Technol Ther (2012) 0.87
Prevalence and Clinical Significance of Discrepancies within Three Computerized Pre-Admission Medication Lists. AMIA Annu Symp Proc (2010) 0.87
Developmental and behavioral questionnaire for autism spectrum disorders. Pediatr Neurol (2007) 0.87
Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia. Glia (2004) 0.86
Prostaglandin I2 signaling drives Th17 differentiation and exacerbates experimental autoimmune encephalomyelitis. PLoS One (2012) 0.85
Improving needle visualization by novice residents during an in-plane ultrasound nerve block simulation using an in-plane multiangle needle guide. Pain Med (2013) 0.85
A Smartphone-based Decision Support Tool Improves Test Performance Concerning Application of the Guidelines for Managing Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy. Anesthesiology (2016) 0.85
Identification and characterization of the interferon-beta-mediated p53 signal pathway in human peripheral blood mononuclear cells. Immunology (2009) 0.84
Predictors of a nondiagnostic epilepsy monitoring study and yield of repeat study. Epilepsy Behav (2011) 0.83
Inflammation and oxidative stress are associated with the prevalence of high aankle-brachial index in metabolic syndrome patients without chronic renal failure. Int J Med Sci (2013) 0.83
Consumer demographics and expectations of probiotic therapy in New Zealand: results of a large telephone survey. N Z Med J (2011) 0.83
Exhaustive measurement of food items in the home using a universal product code scanner. Public Health Nutr (2010) 0.83
Fig4 expression in the rodent nervous system and its potential role in preventing abnormal lysosomal accumulation. J Neuropathol Exp Neurol (2012) 0.82
Comparative effectiveness of maxillomandibular advancement and uvulopalatopharyngoplasty for the treatment of moderate to severe obstructive sleep apnea. J Oral Maxillofac Surg (2012) 0.82
Behavioral coding for evaluation of medical student communication: clarification or obfuscation? Acad Med (2004) 0.82
Successful treatment of six cases of indirect carotid-cavernous fistula with ethylene vinyl alcohol copolymer (Onyx) transvenous embolization. J Neuroophthalmol (2009) 0.82
Comparative short-term safety of bolus versus maintenance iron dosing in hemodialysis patients: a replication study. BMC Nephrol (2014) 0.82
Evolution of intracranial atherosclerotic disease under modern medical therapy. Ann Neurol (2015) 0.81
Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls. PLoS One (2009) 0.81
Trends and variations in intravenous vitamin D use among hemodialysis patients in the United States. Ren Fail (2012) 0.81
Selective local anesthetic placement using ultrasound guidance and neurostimulation for infraclavicular brachial plexus block. Anesth Analg (2010) 0.81
What happens after we identify intimate partner violence? The family physician's perspect. Fam Med (2003) 0.81
Preconditioning with cobalt chloride or desferrioxamine protects oligodendrocyte cell line (MO3.13) from tumor necrosis factor-alpha-mediated cell death. J Neurosci Res (2008) 0.80
Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring. Epilepsy Res (2008) 0.80
Multi-dimensional prioritization of dental caries candidate genes and its enriched dense network modules. PLoS One (2013) 0.80
Effect of mild hyperglycemia on autonomic function in obstructive sleep apnea. Clin Auton Res (2011) 0.80
Cortisol reactivity to experimentally manipulated psychosocial stress in young adults at varied risk for depression. Depress Anxiety (2013) 0.80
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis. J Clin Bioinforma (2013) 0.80
Astrogliopathy and oligodendrogliopathy are early events in CNS demyelination. Glia (2013) 0.80
A structured questionnaire predicts if convulsions are epileptic or nonepileptic. Epilepsy Behav (2010) 0.79
The role of infections in the pathogenesis and course of multiple sclerosis. Ann Indian Acad Neurol (2010) 0.79
Sleep staging and respiratory events in refractory epilepsy patients: Is there a first night effect? Epilepsia (2008) 0.79
Association of Chlamydia pneumoniae with central nervous system disease. Microbes Infect (2003) 0.79